KZA — Kazia Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- AU$18.24m
- AU$14.80m
- AU$0.02m
Australia Stock Exchange release from KAZIA THERAPEUTI : Kazia enrols first patient to PNOC study
Australia Stock Exchange release from KAZIA THERAPEUTI : PRE_NR Ends: 08:45:07
Australia Stock Exchange release from KAZIA THERAPEUTI : Kazia AGM - Results of Meeting
Australia Stock Exchange release from KAZIA THERAPEUTI : PRE_NR Ends: 09:54:14
Australia Stock Exchange release from KAZIA THERAPEUTI : Chairman's Address to Shareholders
Australia Stock Exchange release from KAZIA THERAPEUTI : Notification of cessation of securities - KZA
Australia Stock Exchange release from KAZIA THERAPEUTI : Kazia enrols first patient to EVT801 Phase I clinical trial
Australia Stock Exchange release from KAZIA THERAPEUTI : PRE_NR Ends: 09:49:18
Australia Stock Exchange release from KAZIA THERAPEUTI : PRE_NR Ends: 09:24:14
Australia Stock Exchange release from KAZIA THERAPEUTI : Quarterly Activities/Appendix 4C Cash Flow Report
Australia Stock Exchange release from KAZIA THERAPEUTI : Notice of General Meeting/Proxy Form
Australia Stock Exchange release from KAZIA THERAPEUTI : Kazia AGM date
Australia Stock Exchange release from KAZIA THERAPEUTI : Notification of cessation of securities - KZA
Australia Stock Exchange release from KAZIA THERAPEUTI : Notification regarding unquoted securities - KZA
Australia Stock Exchange release from KAZIA THERAPEUTI : Kazia's EVT801 phase I trial receives regulatory approval
Australia Stock Exchange release from KAZIA THERAPEUTI : Shareholder information - amendment
Brief: Kazia Therapeutics Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Australia Stock Exchange release from KAZIA THERAPEUTI : Change in Directors interests
Australia Stock Exchange release from KAZIA THERAPEUTI : Kazia Annual Report to shareholders